rs754378340
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The ENST00000563236.6(SLC12A3):βc.2533delβ(p.Leu845SerfsTer21) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,461,060 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (β β ). Synonymous variant affecting the same amino acid position (i.e. L844L) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
ENST00000563236.6 frameshift
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC12A3 | NM_001126108.2 | c.2533del | p.Leu845SerfsTer21 | frameshift_variant | 22/26 | ENST00000563236.6 | NP_001119580.2 | |
SLC12A3 | NM_000339.3 | c.2560del | p.Leu854SerfsTer21 | frameshift_variant | 22/26 | NP_000330.3 | ||
SLC12A3 | NM_001126107.2 | c.2557del | p.Leu853SerfsTer21 | frameshift_variant | 22/26 | NP_001119579.2 | ||
SLC12A3 | NM_001410896.1 | c.2530del | p.Leu844SerfsTer21 | frameshift_variant | 22/26 | NP_001397825.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC12A3 | ENST00000563236.6 | c.2533del | p.Leu845SerfsTer21 | frameshift_variant | 22/26 | 1 | NM_001126108.2 | ENSP00000456149 | A1 | |
SLC12A3 | ENST00000438926.6 | c.2560del | p.Leu854SerfsTer21 | frameshift_variant | 22/26 | 1 | ENSP00000402152 | A1 | ||
SLC12A3 | ENST00000566786.5 | c.2557del | p.Leu853SerfsTer21 | frameshift_variant | 22/26 | 1 | ENSP00000457552 | P4 | ||
SLC12A3 | ENST00000262502.5 | c.2530del | p.Leu844SerfsTer21 | frameshift_variant | 22/26 | 5 | ENSP00000262502 | A1 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 exomes AF: 0.00000400 AC: 1AN: 250264Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 135222
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461060Hom.: 0 Cov.: 31 AF XY: 0.00000275 AC XY: 2AN XY: 726748
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Familial hypokalemia-hypomagnesemia Pathogenic:2
Pathogenic, no assertion criteria provided | clinical testing | Natera, Inc. | Mar 02, 2021 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Mar 18, 2022 | - - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | Athena Diagnostics | Apr 06, 2018 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 20, 2023 | This variant is present in population databases (rs754378340, gnomAD 0.0009%). For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 586604). This premature translational stop signal has been observed in individual(s) with Gitelman syndrome (PMID: 25422309). This sequence change creates a premature translational stop signal (p.Leu854Serfs*21) in the SLC12A3 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in SLC12A3 are known to be pathogenic (PMID: 20848653, 22009145, 25841442). - |
Inborn genetic diseases Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Ambry Genetics | Feb 22, 2021 | The c.2560delC (p.L854Sfs*21) alteration, located in coding exon 22 of the SLC12A3 gene, consists of a deletion of one nucleotide at position 2560, causing a translational frameshift with a predicted alternate stop codon after 21 amino acids. This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. This alteration was reported to occur with a second splice site alteration in a male patient diagnosed with Gitelman syndrome (Corbetta, 2015). Based on the available evidence, this alteration is classified as pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at